Dr. Munjal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Albert Einstein College of Medicine
Pediatrics
Bronx, NY 10467Phone+1 718-741-2471
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Infectious Diseases, 2009 - 2012
- Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2005 - 2009
- Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
- NY State Medical License 2007 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 2 citationsEfficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE tr...Takeo Otsuki, Shinobu Akada, Ai Anami, Kenzo Kosaka, Iona Munjal
Vaccine. 2024-09-17 - 1 citationsEquivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: Results of a randomized phase 3 study.Jeffrey Baker, Negar Aliabadi, Iona Munjal, Qin Jiang, Ye Feng
Vaccine. 2024-05-10 - 9 citationsEfficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.Hamid Hassanzadeh, James Baber, Elizabeth Begier, David C Noriega, Hiroaki Konishi
Clinical Infectious Diseases. 2023-07-26
Journal Articles
- Predictors of Inadequate Initial Echocardiography in Suspected Kawasaki Disease: Criteria for SedationNadine F Choueiter, Iona M Munjal, Chhavi Katyal, Congenital Heart Disease
Press Mentions
- International and Regional Experts Address the Role of Vaccines in Disease Management During Pfizer MERA Vaccines Summit 2024November 4th, 2024
- Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect InfantsMarch 23rd, 2023
- Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59April 10th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: